CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF
Patent Cooperation Treaty
PCT/US2023/062525
Filed on 2023-02-14
PCT/US2023/062525
Filed on 2023-02-14
AGENTS FOR SENSITIZING SOLID TUMORS TO TREATMENT
US Application 18/012,260
Filed on 2022-12-22
Filed on 2022-12-22
CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2
European Patent
20802725.0
Filed on 2020-05-06
20802725.0
Filed on 2020-05-06
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
European Patent
21752355.4
Filed on 2023-02-10
21752355.4
Filed on 2023-02-10
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
US Application 18/015,781
Filed on 2023-01-12
Filed on 2023-01-12
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS
WITH G12V MUTATION
Singapore
11202300139Y
Filed on 2023-01-06
11202300139Y
Filed on 2023-01-06
HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation
South Korea
20237005176
Filed on 2023-02-14
20237005176
Filed on 2023-02-14
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
China
202180050745.7
Filed on 2023-02-17
202180050745.7
Filed on 2023-02-17
HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation
Australia
2021309958
Filed on 2023-01-11
2021309958
Filed on 2023-01-11